New gel aims to stop painful side effect of chemotherapy
Symptom relief
Not yet recruiting
This study tests a gel called TAR-0520 to prevent hand-foot syndrome, a painful skin reaction caused by the chemotherapy drug capecitabine. About 25 people with breast or colorectal cancer will apply the gel to their hands twice daily for 12 weeks. The goal is to see if the gel i…
Phase: PHASE2 • Sponsor: Tarian Pharma • Aim: Symptom relief
Last updated May 14, 2026 12:05 UTC